Fig. 1From: Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional studyThe Z-scores of the BMD of the spine (L2–4) in the whole study population. The black portion indicates the participants with a history of fractureBack to article page